VIJOICE
LIVE

Serial Number

79284023

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

VIJOICE Trademark

Serial Number: 79284023 • Registration: 6202903

VIJOICE is a trademark filed by NOVARTIS AG on March 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 10, 2020

Registration Date

November 24, 2020

Published for Opposition

September 8, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 24, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2021 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Feb 28, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 27, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 24, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 24, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 29, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 29, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 29, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 29, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 29, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 29, 2020 COAR
REFUSAL PROCESSED BY IB
Jul 18, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 27, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jun 27, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 28, 2020 RFCR
NON-FINAL ACTION WRITTEN
May 27, 2020 CNRT
ASSIGNED TO EXAMINER
May 27, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
May 5, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 30, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 29, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 23, 2020 REPR